Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL10P3, also known as ribosomal protein L10 pseudogene 3, is a processed pseudogene derived from the parental RPL10 gene, which encodes a component of the 60S ribosomal subunit essential for ribosome assembly and protein synthesis in eukaryotes[3][7]. However, as a pseudogene, RPL10P3 does not encode a protein and lacks known biological or therapeutic relevance[5][6]. Pseudogenes such as RPL10P3 are generally considered non-functional genomic sequences resulting from duplication or retrotransposition events, and are not included among canonical drug targets, biomarkers, or disease-associated genes in current biomedical research[5][6].\nIf your intent was to find information on the bona fide protein ribosomal protein L10 (RPL10), that protein is functional and related to ribosome biogenesis, protein synthesis, and signal transduction, and has known disease associations, but RPL10P3 itself is not therapeutically or biologically active[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ribosomal protein L10 pseudogene 3 (RPL10P3).